Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
Conditions
- Adult Diffuse Large B-Cell Lymphoma
- B-Cell Non-Hodgkin Lymphoma
- Follicular Lymphoma
- Mantle Cell Lymphoma
- Non-Hodgkin Lymphoma
- T-Cell Non-Hodgkin Lymphoma
Interventions
- PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
- DRUG: Bortezomib
- DRUG: Carmustine
- DRUG: Cytarabine
- DRUG: Etoposide
- DRUG: Melphalan
- DRUG: Rituximab
- DRUG: Vorinostat
Sponsor
Fred Hutchinson Cancer Center
Collaborators